MetaCap

BriaCell Therapeutics Statistics

NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.06-0.105 (-3.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BriaCell Therapeutics by the numbers

BriaCell Therapeutics has a market capitalization of $26.7 million based on 8.73M shares outstanding. With trailing EPS of $-6.97, BriaCell Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.9% below its 50-day average and 18.1% below its 200-day average.

Average daily trading volume is 250.81K shares, or about $767,485 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BCTX valuation vs. peer median

BCTX compared with the median of 8 peer companies
MetricBCTXPeer medianDifference
Market cap$26.72M$28.67M-7%
Avg. volume250.81K153.03K+64%

Peer median across 8 companies: TELO, NSRX, EDSA, PMN, AYTU, ATHE, RNTX, NNVC.

Valuation

Price and trading

Previous close
3.17
Open
3.14
Day range
3.02 – 3.20
52-week range
2.60 – 13.09
52-week change
-61.75%
Beta
—
Volume
109.66K

Dividends and events

Annual dividend
None
Next earnings date
Dec 10, 2026

Additional statistics

Market Cap
26.72M
Forward Pe
-7.85
Eps
-6.97
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
13.09
Week52 Low
2.60
Avg Volume
250.81K
Shares Outstanding
8.73M
Ma50
3.68
Ma200
3.74
Earnings Date
Dec 10, 2026
Pct From52w High
-76.62%
Pct From52w Low
17.69%

Related